Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes

Ellen Fritsche, Philippe Grandjean, Kevin M. Crofton, Michael Aschner, Alan Goldberg, Tuula Heinonen, Ellen V.S. Hessel, Helena T. Hogberg, Susanne Hougaard Bennekou, Pamela J Lein, Marcel Leist, William R. Mundy, Martin Paparella, Aldert H. Piersma, Magdalini Sachana, Gabriele Schmuck, Roland Solecki, Andrea Terron, Florianne Monnet-Tschudi, Martin F. Wilks & 3 others Hilda Witters, Marie Gabrielle Zurich, Anna Bal-Price

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.

Original languageEnglish (US)
JournalToxicology and Applied Pharmacology
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Consensus
Innovation
Needs Assessment
Environmental Exposure
Testing
Neuroglia
Biological Assay
Computer Simulation
Uncertainty
Industry
Stem Cells
Bioassay
Guidelines
Stem cells
Toxicity
Brain
Animals
In Vitro Techniques
Neurodevelopmental Disorders
Genetics

Keywords

  • Developmental neurotoxicity
  • In vitro testing
  • Regulatory purposes

ASJC Scopus subject areas

  • Toxicology
  • Pharmacology

Cite this

Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. / Fritsche, Ellen; Grandjean, Philippe; Crofton, Kevin M.; Aschner, Michael; Goldberg, Alan; Heinonen, Tuula; Hessel, Ellen V.S.; Hogberg, Helena T.; Bennekou, Susanne Hougaard; Lein, Pamela J; Leist, Marcel; Mundy, William R.; Paparella, Martin; Piersma, Aldert H.; Sachana, Magdalini; Schmuck, Gabriele; Solecki, Roland; Terron, Andrea; Monnet-Tschudi, Florianne; Wilks, Martin F.; Witters, Hilda; Zurich, Marie Gabrielle; Bal-Price, Anna.

In: Toxicology and Applied Pharmacology, 01.01.2018.

Research output: Contribution to journalArticle

Fritsche, E, Grandjean, P, Crofton, KM, Aschner, M, Goldberg, A, Heinonen, T, Hessel, EVS, Hogberg, HT, Bennekou, SH, Lein, PJ, Leist, M, Mundy, WR, Paparella, M, Piersma, AH, Sachana, M, Schmuck, G, Solecki, R, Terron, A, Monnet-Tschudi, F, Wilks, MF, Witters, H, Zurich, MG & Bal-Price, A 2018, 'Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes', Toxicology and Applied Pharmacology. https://doi.org/10.1016/j.taap.2018.02.004
Fritsche, Ellen ; Grandjean, Philippe ; Crofton, Kevin M. ; Aschner, Michael ; Goldberg, Alan ; Heinonen, Tuula ; Hessel, Ellen V.S. ; Hogberg, Helena T. ; Bennekou, Susanne Hougaard ; Lein, Pamela J ; Leist, Marcel ; Mundy, William R. ; Paparella, Martin ; Piersma, Aldert H. ; Sachana, Magdalini ; Schmuck, Gabriele ; Solecki, Roland ; Terron, Andrea ; Monnet-Tschudi, Florianne ; Wilks, Martin F. ; Witters, Hilda ; Zurich, Marie Gabrielle ; Bal-Price, Anna. / Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes. In: Toxicology and Applied Pharmacology. 2018.
@article{759af48403a941a48c28dfdfea732f63,
title = "Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes",
abstract = "This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.",
keywords = "Developmental neurotoxicity, In vitro testing, Regulatory purposes",
author = "Ellen Fritsche and Philippe Grandjean and Crofton, {Kevin M.} and Michael Aschner and Alan Goldberg and Tuula Heinonen and Hessel, {Ellen V.S.} and Hogberg, {Helena T.} and Bennekou, {Susanne Hougaard} and Lein, {Pamela J} and Marcel Leist and Mundy, {William R.} and Martin Paparella and Piersma, {Aldert H.} and Magdalini Sachana and Gabriele Schmuck and Roland Solecki and Andrea Terron and Florianne Monnet-Tschudi and Wilks, {Martin F.} and Hilda Witters and Zurich, {Marie Gabrielle} and Anna Bal-Price",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.taap.2018.02.004",
language = "English (US)",
journal = "Toxicology and Applied Pharmacology",
issn = "0041-008X",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes

AU - Fritsche, Ellen

AU - Grandjean, Philippe

AU - Crofton, Kevin M.

AU - Aschner, Michael

AU - Goldberg, Alan

AU - Heinonen, Tuula

AU - Hessel, Ellen V.S.

AU - Hogberg, Helena T.

AU - Bennekou, Susanne Hougaard

AU - Lein, Pamela J

AU - Leist, Marcel

AU - Mundy, William R.

AU - Paparella, Martin

AU - Piersma, Aldert H.

AU - Sachana, Magdalini

AU - Schmuck, Gabriele

AU - Solecki, Roland

AU - Terron, Andrea

AU - Monnet-Tschudi, Florianne

AU - Wilks, Martin F.

AU - Witters, Hilda

AU - Zurich, Marie Gabrielle

AU - Bal-Price, Anna

PY - 2018/1/1

Y1 - 2018/1/1

N2 - This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.

AB - This consensus statement voices the agreement of scientific stakeholders from regulatory agencies, academia and industry that a new framework needs adopting for assessment of chemicals with the potential to disrupt brain development. An increased prevalence of neurodevelopmental disorders in children has been observed that cannot solely be explained by genetics and recently pre- and postnatal exposure to environmental chemicals has been suspected as a causal factor. There is only very limited information on neurodevelopmental toxicity, leaving thousands of chemicals, that are present in the environment, with high uncertainty concerning their developmental neurotoxicity (DNT) potential. Closing this data gap with the current test guideline approach is not feasible, because the in vivo bioassays are far too resource-intensive concerning time, money and number of animals. A variety of in vitro methods are now available, that have the potential to close this data gap by permitting mode-of-action-based DNT testing employing human stem cells-derived neuronal/glial models. In vitro DNT data together with in silico approaches will in the future allow development of predictive models for DNT effects. The ultimate application goals of these new approach methods for DNT testing are their usage for different regulatory purposes.

KW - Developmental neurotoxicity

KW - In vitro testing

KW - Regulatory purposes

UR - http://www.scopus.com/inward/record.url?scp=85042428147&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85042428147&partnerID=8YFLogxK

U2 - 10.1016/j.taap.2018.02.004

DO - 10.1016/j.taap.2018.02.004

M3 - Article

JO - Toxicology and Applied Pharmacology

JF - Toxicology and Applied Pharmacology

SN - 0041-008X

ER -